You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Romidepsin

Showing 26 - 50 of 98
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoid Malignancies, Multiple Myeloma, Lymphoma Trial in Boston, New York (Pralatrexate, Romidepsin)

Unknown status
  • Lymphoid Malignancies
  • +4 more
  • Boston, Massachusetts
  • +1 more
Feb 6, 2020

Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell

Completed
Has Results
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx
  • +3 more
  • romidepsin
  • Boston, Massachusetts
  • +1 more
Feb 11, 2021

Mycosis Fungoides, Cutaneous T-Cell Lymphoma, Tumors Trial run by the NCI (Romidepsin (FR901228))

Terminated
  • Mycosis Fungoides
  • +2 more
  • Romidepsin (FR901228)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Lymphoma, Cancer Trial in Sarasota, Nashville, London (Romidepsin)

Completed
Has Results
  • Lymphoma
  • Cancer
  • Romidepsin
  • Sarasota, Florida
  • +2 more
Nov 14, 2019

Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Rifampin)

Completed
Has Results
  • Hematologic Malignancy
  • Malignant Lymphoma
  • Sarasota, Florida
  • +2 more
Nov 14, 2019

Hematologic Malignancy, Malignant Lymphoma Trial in Sarasota, Nashville, London (Romidepsin, Ketoconazole)

Completed
Has Results
  • Hematologic Malignancy
  • Malignant Lymphoma
  • Sarasota, Florida
  • +2 more
Nov 14, 2019

Pancreatic Cancer Trial in Nashville (Romidepsin, Gemcitabine)

Completed
Has Results
  • Pancreatic Cancer
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 16, 2019

Peripheral T-cell Lymphoma Trial in Italy (Romidepsin + Gemcitabine)

Completed
Has Results
  • Peripheral T-cell Lymphoma
  • Romidepsin + Gemcitabine
  • Alessandria, Italy
  • +3 more
Oct 11, 2019

HIV Trial (HIVACAR, )

Unknown status
  • HIV Infections
  • HIVACAR
  • placebo
  • (no location specified)
Mar 27, 2020

Multiple Myeloma Trial in United States (Bortezomib, Romidepsin)

Terminated
Has Results
  • Multiple Myeloma
  • Loma Linda, California
  • +11 more
Nov 14, 2019

Tumors Trial run by the NCI (Depsipeptide, FR901228, FK228)

Completed
  • Neoplasms
  • Depsipeptide, FR901228, FK228
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019

Prostate Cancer, Metastases Trial (Romidepsin)

Completed
  • Prostate Cancer
  • Metastases
  • Romidepsin
  • (no location specified)
Nov 14, 2019

Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell

Terminated
Has Results
  • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
  • +13 more
  • Chicago, Illinois
    Northwestern University
Jul 24, 2019

Carcinoma, Renal Cell, Tumor Metastasis Trial in Duarte, Chicago, Seattle (FK228 (romidepsin))

Completed
  • Carcinoma, Renal Cell
  • Neoplasm Metastasis
  • FK228 (romidepsin)
  • Duarte, California
  • +2 more
Oct 16, 2019

Carcinoma, Renal Cell, Prostatic Tumors Trial in United Kingdom, United States (FK228 (romidepsin))

Completed
  • Carcinoma, Renal Cell
  • Prostatic Neoplasms
  • FK228 (romidepsin)
  • Duarte, California
  • +4 more
Nov 14, 2019

Lymphoma, T-Cell, Peripheral Trial (Romidepsin, Pralatrexate)

Withdrawn
  • Lymphoma, T-Cell, Peripheral
  • (no location specified)
Dec 17, 2018

Peripheral T-cell Lymphoma Trial in Worldwide (Romidepsin)

Completed
Has Results
  • Peripheral T-cell Lymphoma
  • Romidepsin
  • La Jolla, California
  • +89 more
Jan 29, 2020

Lymphoma, T-cell, Peripheral Trial in Japan (Romidepsin)

Completed
Has Results
  • Lymphoma, T-cell, Peripheral
  • Romidepsin
  • Nagoya, Aichi, Japan
  • +16 more
Jan 28, 2019

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

ISTODAX® for Intravenous Infusion Drug Use Results Survey-

Recruiting
  • Lymphoma, T-Cell, Peripheral
  • Osaka, Japan
    Nihon Seimei Hospital
Jun 1, 2021

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

Recruiting
  • Cutaneous T Cell Lymphoma
  • Peripheral T Cell Lymphoma
  • Microdevices
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 16, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed
Has Results
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Chemosensitivity Assay
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 29, 2022

Multiple Myeloma Trial in New York (Romidepsin, pomalidomide, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • Romidepsin
  • +2 more
  • New York, New York
    Weill Cornell Medical College
May 31, 2018

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021